AbbVie Declares Quarterly Dividend
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
AbbVie (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on August 15, 2025, to stockholders of record as of July 15, 2025. The pharmaceutical company has demonstrated strong commitment to shareholder returns, increasing its dividend by 310 percent since its establishment in 2013. AbbVie's consistent dividend growth has earned it a place in the prestigious S&P Dividend Aristocrats Index, which includes companies that have raised their dividends for at least 25 consecutive years.
AbbVie (NYSE: ABBV) ha annunciato un dividendo in contanti trimestrale di 1,64 dollari per azione, pagabile il 15 agosto 2025 agli azionisti registrati al 15 luglio 2025. L'azienda farmaceutica ha dimostrato un forte impegno verso i rendimenti per gli azionisti, aumentando il dividendo del 310% dal 2013, anno della sua fondazione. La crescita costante dei dividendi di AbbVie le ha valso un posto nel prestigioso S&P Dividend Aristocrats Index, che include societ脿 che hanno incrementato i loro dividendi per almeno 25 anni consecutivi.
AbbVie (NYSE: ABBV) ha anunciado un dividendo trimestral en efectivo de 1,64 d贸lares por acci贸n, pagadero el 15 de agosto de 2025 a los accionistas registrados al 15 de julio de 2025. La compa帽铆a farmac茅utica ha demostrado un fuerte compromiso con los rendimientos para los accionistas, aumentando su dividendo en un 310% desde su fundaci贸n en 2013. El crecimiento constante del dividendo de AbbVie le ha otorgado un lugar en el prestigioso S&P Dividend Aristocrats Index, que incluye empresas que han incrementado sus dividendos durante al menos 25 a帽os consecutivos.
AbbVie(NYSE: ABBV)電� 2025雲� 8鞗� 15鞚检棎 歆�旮夒悹 欤茧嫻 1.64雼煬鞚� 攵勱赴 順勱笀 氚半嫻旮堨潉 氚滍憸頄堨溂氅�, 2025雲� 7鞗� 15鞚� 旮办 欤检＜霌れ棎瓴� 歆�旮夒惄雼堧嫟. 鞚� 鞝滌暯須岇偓電� 2013雲� 靹る 鞚错泟 氚半嫻旮堨潉 310% 鞚胳儊頃橂┌ 欤检＜ 靾橃澋鞐� 雽�頃� 臧曧暅 鞚橃毳� 氤挫棳欤缄碃 鞛堨姷雼堧嫟. AbbVie鞚� 昃胳頃� 氚半嫻旮� 歃濌皜電� 斓滌唽 25雲� 鞐办啀 氚半嫻旮堨潉 鞚胳儊頃� 旮办梾霌れ澊 韽暔霅� 甓岇渼 鞛堧姅 S&P Dividend Aristocrats 歆�靾橃棎 鞚措鞚� 鞓Μ瓴� 頄堨姷雼堧嫟.
AbbVie (NYSE : ABBV) a annonc茅 un dividende trimestriel en esp猫ces de 1,64 $ par action, payable le 15 ao没t 2025 aux actionnaires inscrits au 15 juillet 2025. La soci茅t茅 pharmaceutique a d茅montr茅 un fort engagement envers le rendement des actionnaires, augmentant son dividende de 310 % depuis sa cr茅ation en 2013. La croissance constante des dividendes d'AbbVie lui a valu une place dans le prestigieux S&P Dividend Aristocrats Index, qui regroupe les entreprises ayant augment茅 leurs dividendes pendant au moins 25 ann茅es cons茅cutives.
AbbVie (NYSE: ABBV) hat eine viertelj盲hrliche Bardividende von 1,64 USD pro Aktie angek眉ndigt, zahlbar am 15. August 2025 an Aktion盲re, die am 15. Juli 2025 im Register stehen. Das Pharmaunternehmen zeigt ein starkes Engagement f眉r Aktion盲rsrenditen und hat seine Dividende seit der Gr眉ndung im Jahr 2013 um 310 Prozent erh枚ht. Das kontinuierliche Dividendenwachstum von AbbVie hat dem Unternehmen einen Platz im renommierten S&P Dividend Aristocrats Index eingebracht, der Unternehmen umfasst, die ihre Dividenden mindestens 25 Jahre in Folge erh枚ht haben.
Positive
- Quarterly dividend of $1.64 per share maintains consistent shareholder returns
- Impressive 310% dividend growth since 2013 demonstrates strong financial performance
- Inclusion in S&P Dividend Aristocrats Index reflects reliable dividend growth history
Negative
- None.
The cash dividend is payable August 15, 2025, to stockholders of record at the close of business on July 15, 2025.
Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care 鈥� and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at . Follow @abbvie on 听, , 听and
Media: | Investors: |
Gabby Tarbert | Liz Shea |
(224) 244-0111 | (847) 935-2211 |
听
View original content:
SOURCE AbbVie
FAQ
What is AbbVie's (ABBV) quarterly dividend payment for Q3 2025?
AbbVie's quarterly dividend payment for Q3 2025 is $1.64 per share, payable on August 15, 2025, to stockholders of record as of July 15, 2025.
How much has AbbVie's dividend increased since 2013?
AbbVie has increased its dividend by 310 percent since its inception in 2013.
When is the record date for AbbVie's Q3 2025 dividend?
The record date for AbbVie's Q3 2025 dividend is July 15, 2025.
Is AbbVie (ABBV) a Dividend Aristocrat?
Yes, AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have increased their dividend annually for at least 25 consecutive years.
Abbvie Inc
NYSE:ABBV
ABBV Rankings
ABBV Latest News
ABBV Latest SEC Filings
Jul 7, 2025
[SCHEDULE 13G/A] ABBVIE INC. SEC Filing
Jul 3, 2025
[8-K] ABBVIE INC. Reports Material Event
Jul 2, 2025
[Form 4] ABBVIE INC. Insider Trading Activity
Jul 2, 2025
[Form 4] ABBVIE INC. Insider Trading Activity
Jul 2, 2025
[Form 4] ABBVIE INC. Insider Trading Activity
ABBV Stock Data
334.34B
1.76B
0.12%
74.08%
1.05%
Drug Manufacturers - General
Pharmaceutical Preparations
United States
NORTH CHICAGO